Two Drug Update

Associated Courses



The purpose of this course is to familiarize providers with a comparative review of two drugs, Siponimod and Sotagliflozin. Siponimod is a drug that could potentially improve the quality of life of patients suffering from Multiple Sclerosis. Sotagliflozin is a medication that could potentially be used in combination with regular insulin therapy to reduce patient blood sugar levels and help keep them low for a longer period of time.

1 CE

This continuing nursing education activity was approved by the Colorado Nurses Association, an
accredited approver by the American Nurses Credentialing Center’s Commission on


There are no reviews yet.

Be the first to review “Two Drug Update”

Your email address will not be published. Required fields are marked *